Figure 2 | Scientific Reports

Figure 2

From: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19

Figure 2

Activity of TMPRSS2 in the presence of AAT. (A) HEK293TTMPRSS2 cells were left untreated or pre-treated with AAT at the indicated final concentrations or AEBSF (50 µM) for 30 min, followed by addition of the fluorogenic substrate Boc-QAR-AMC. Fluorescence was measured immediately on the fluorescent plate reader and then every 15 min for a total of 90 min. (B) TMPRSS2 activity at 90 min. Data shown are the triplicate means ± SEM of three independent experiments. *p < 0.05, **p < 0.01 at 90 min compared to untreated cells. AAT = alpha-1-antitrypsin.

Back to article page